CLINICAL_TRIALS
trial_result
· 2016-05-26
Clinical Trial Update: Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat [Phase 3]
Summary
A Phase 3 clinical trial evaluating the combination of lesinurad and febuxostat for tophaceous gout has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ardea Biosciences, Inc. | Conditions: Tophaceous Gout | Phase 3 | Status: COMPLETED | Results posted: 2016-05-26